Pfizer reported yesterday in a press release that Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of the study. This news was according to a pooled analysis presented on Wednesday, 4/16/08, at the American Academy of Neurology annual meeting.
The study also revealed that patients self-reported improvements were more closely associated with improvements in pain and sleep than with improvements in fatigue or symptoms of anxiety or depression.
Dr. Lesley Arnold, one of the study authors said:
“The data showed that Lyrica reduced fibromyalgia pain, and alleviating that pain was associated with patients overall feeling of well-being. Understandably, many patients with a chronic pain condition such as fibromyalgia also experience depression and anxiety, and importantly we found that Lyrica helped reduce pain in patients regardless of the presence of symptoms of these co-morbid conditions.
Lyrica is prescribed in the U.S. for treating Fibromyalgia and also for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia (pain after shingles), and as adjunctive therapy for adults with partial onset seizures